204 related articles for article (PubMed ID: 15240156)
1. Beta-2 glycoprotein I and its role in antiphospholipid syndrome-lessons from knockout mice.
Miyakis S; Robertson SA; Krilis SA
Clin Immunol; 2004 Aug; 112(2):136-43. PubMed ID: 15240156
[TBL] [Abstract][Full Text] [Related]
2. Bacterial induction of autoantibodies to beta2-glycoprotein-I accounts for the infectious etiology of antiphospholipid syndrome.
Blank M; Krause I; Fridkin M; Keller N; Kopolovic J; Goldberg I; Tobar A; Shoenfeld Y
J Clin Invest; 2002 Mar; 109(6):797-804. PubMed ID: 11901188
[TBL] [Abstract][Full Text] [Related]
3. Beta 2 glycoprotein I--function in health and disease.
Miyakis S; Giannakopoulos B; Krilis SA
Thromb Res; 2004; 114(5-6):335-46. PubMed ID: 15507263
[TBL] [Abstract][Full Text] [Related]
4. Anti-beta 2-glycoprotein I autoantibodies from patients with the "antiphospholipid" syndrome bind to beta 2-glycoprotein I with low affinity: dimerization of beta 2-glycoprotein I induces a significant increase in anti-beta 2-glycoprotein I antibody affinity.
Sheng Y; Kandiah DA; Krilis SA
J Immunol; 1998 Aug; 161(4):2038-43. PubMed ID: 9712077
[TBL] [Abstract][Full Text] [Related]
5. Ontogeny of beta 2 glycoprotein I and annexin V in villous placenta of normal and antiphospholipid syndrome pregnancies.
Donohoe S; Kingdom JC; Mackie IJ; Burrell S; Quenby S; Jauniaux E; Machin SJ
Thromb Haemost; 2000 Jul; 84(1):32-8. PubMed ID: 10928466
[TBL] [Abstract][Full Text] [Related]
6. Beta2-glycoprotein I, anti-beta2-glycoprotein I, and fibrinolysis.
Yasuda S; Atsumi T; Ieko M; Koike T
Thromb Res; 2004; 114(5-6):461-5. PubMed ID: 15507279
[TBL] [Abstract][Full Text] [Related]
7. Oral tolerance to low dose beta 2-glycoprotein I: immunomodulation of experimental antiphospholipid syndrome.
Blank M; George J; Barak V; Tincani A; Koike T; Shoenfeld Y
J Immunol; 1998 Nov; 161(10):5303-12. PubMed ID: 9820503
[TBL] [Abstract][Full Text] [Related]
8. Anti-beta2-glycoprotein I antibodies recognizing platelet factor 4-heparin complex in antiphospholipid syndrome in patient substantiated with mouse model.
Bourhim M; Darnige L; Legallais C; Arvieux J; Cevallos R; Pouplard C; Vijayalakshmi MA
J Mol Recognit; 2003; 16(3):125-30. PubMed ID: 12833567
[TBL] [Abstract][Full Text] [Related]
9. Overlapping humoral autoimmunity links rheumatic fever and the antiphospholipid syndrome.
Blank M; Krause I; Magrini L; Spina G; Kalil J; Jacobsen S; Thiesen HJ; Cunningham MW; Guilherme L; Shoenfeld Y
Rheumatology (Oxford); 2006 Jul; 45(7):833-41. PubMed ID: 16705050
[TBL] [Abstract][Full Text] [Related]
10. Antibodies to beta2-glycoprotein I associated with antiphospholipid syndrome suppress the inhibitory activity of tissue factor pathway inhibitor.
Salemink I; Blezer R; Willems GM; Galli M; Bevers E; Lindhout T
Thromb Haemost; 2000 Oct; 84(4):653-6. PubMed ID: 11057865
[TBL] [Abstract][Full Text] [Related]
11. Beta2-glycoprotein I protects thrombin from inhibition by heparin cofactor II: potentiation of this effect in the presence of anti-beta2-glycoprotein I autoantibodies.
Rahgozar S; Giannakopoulos B; Yan X; Wei J; Cheng Qi J; Gemmell R; Krilis SA
Arthritis Rheum; 2008 Apr; 58(4):1146-55. PubMed ID: 18383370
[TBL] [Abstract][Full Text] [Related]
12. Detection and characterization of B cell epitopes on beta2-glycoprotein I.
Cockerill KA; Linnik MD; Iverson GM
Clin Immunol; 2004 Aug; 112(2):129-35. PubMed ID: 15240155
[TBL] [Abstract][Full Text] [Related]
13. Induction of antiphospholipid antibodies and antiphospholipid syndrome-like autoimmunity in naive mice with antibody against human parvovirus B19 VP1 unique region protein.
Tzang BS; Lee YJ; Yang TP; Tsay GJ; Shi JY; Tsai CC; Hsu TC
Clin Chim Acta; 2007 Jul; 382(1-2):31-6. PubMed ID: 17451664
[TBL] [Abstract][Full Text] [Related]
14. Effect of beta2-glycoprotein I null mutation on reproductive outcome and antiphospholipid antibody-mediated pregnancy pathology in mice.
Robertson SA; Roberts CT; van Beijering E; Pensa K; Sheng Y; Shi T; Krilis SA
Mol Hum Reprod; 2004 Jun; 10(6):409-16. PubMed ID: 15100383
[TBL] [Abstract][Full Text] [Related]
15. Libman-Sacks endocarditis associated with antiphospholipid syndrome and infection.
Blank M; Shani A; Goldberg I; Kopolovic J; Amigo MC; Magrini L; Shoenfeld Y
Thromb Res; 2004; 114(5-6):589-92. PubMed ID: 15507295
[TBL] [Abstract][Full Text] [Related]
16. Novel considerations in the pathogenesis of the antiphospholipid syndrome: involvement of the tissue factor pathway of blood coagulation.
Adams M
Semin Thromb Hemost; 2008 Apr; 34(3):251-5. PubMed ID: 18720304
[TBL] [Abstract][Full Text] [Related]
17. Beta-2-glycoprotein-I, infections, antiphospholipid syndrome and therapeutic considerations.
Blank M; Shoenfeld Y
Clin Immunol; 2004 Aug; 112(2):190-9. PubMed ID: 15240163
[TBL] [Abstract][Full Text] [Related]
18. Revisiting beta 2 glycoprotein I, the major autoantigen in the antiphospholipid syndrome.
Rahgozar S
Iran J Immunol; 2012 Jun; 9(2):73-85. PubMed ID: 22735795
[TBL] [Abstract][Full Text] [Related]
19. Beta2-glycoprotein I: antiphospholipid syndrome and T-cell reactivity.
Kuwana M
Thromb Res; 2004; 114(5-6):347-55. PubMed ID: 15507264
[TBL] [Abstract][Full Text] [Related]
20. A peptide that shares similarity with bacterial antigens reverses thrombogenic properties of antiphospholipid antibodies in vivo.
Pierangeli SS; Blank M; Liu X; Espinola R; Fridkin M; Ostertag MV; Roye-Green K; Harris EN; Shoenfeld Y
J Autoimmun; 2004 May; 22(3):217-25. PubMed ID: 15041042
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
